Coming back to: Private prescribing in the UK: what is actually involved posts 61–68
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I read the earlier replies on Private prescribing twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
This is the answer, and the reason it is the answer is the more useful part.
Building on post #61 rather than restating it.
A note on how Private prescribing gets discussed rather than on Private prescribing itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.
Everything in post #61 holds. The case it does not cover is the one I have.
Where a member reports a decision, the useful detail is the stated reason rather than the outcome, because the reason is what generalises.
I would not lead a decision with this, but I would not ignore it either.
Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.
Where the Private prescribing discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
This topic was referenced in
- NHS criteria and how they are applied in practice — the long versionRegional › UK & Ireland · 15 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
|
+3 | 7 | 357 | 3mo |
|
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
|
+46 | 53 | 14k | 12mo |
|
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on behalf of the question I keep seeing asked…
|
+95 | 105 | 1.3k | 4mo |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
|
+10 | 14 | 27k | 2d |
|
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I have read four threads on it and each…
|
2 | 44k | 22mo |
Related topics — sharing the tags personal import, MHRA, NHS
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The question about Cross-border purchase within…
|
+135 | 139 | 8.7k | 16mo |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
|
+10 | 14 | 27k | 2d |
|
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have read four threads on it and each…
|
+93 | 101 | 2.2k | 5mo |
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
|
+70 | 74 | 7k | 8mo |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
|
+50 | 56 | 780 | 8mo |